An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)

Clinical trial NCT03749447 · TERMINATED

Trial details

NCT number: NCT03749447
Sponsor: Biogen
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Diseases Alport Syndrome Autosomal Dominant Polycystic Kidney

Start date: 2019-03-08
Primary completion: 2023-08-23
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.